1 year return (CAGR)
10.35%
A2A S.p.A Exchange (MI, EUR)
A2A.MI
-
-0.03 (-1.28%)
UtilitiesUtilities - Diversified
Loading...
3 year return (CAGR)
21.17%
5 year return (CAGR)
11.56%
10 year return (CAGR)
8.31%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
7.70B
Price/Sales
0.37
Ent value
-
Price/Book
1.36
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
6.35
PEG
-
Forward P/E
11.30
EPS growth
17.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 2.48 |
| Daily high | 2.48 |
| Daily low | 2.42 |
| Daily Volume | 22.2M |
| 1y analyst estimate | 2.61 |
| Beta | 0.94 |
| EPS (TTM) | 0.39 |
| Dividend per share | 0.00 |
| Ex-div date | 20 May 2025 |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| A2A.MI | S&P500 | |
| Current price drop from All-time high | -70.16% | -1.98% |
| Highest price drop | -96.50% | -56.47% |
| Date of highest drop | 24 Jul 2012 | 9 Mar 2009 |
| Avg drop from high | -76.21% | -10.67% |
| Avg time to new high | 117 days | 12 days |
| Max time to new high | 6580 days | 1805 days |
News
Premium ceramics manufacturer unifies customer operations across its Dining & Lifestyle and Bathroom & Wellness divisions to deliver seamless, personalized experiences worldwidePALO ALTO, Calif. and M...
October 8, 2026
SAINT-PRIEST, France, October 08, 2026--Regulatory News: Jacquet Metals SA (Paris:JCQ):
October 8, 2026
BAYRY's Kerendia label expansion moves forward as FDA accepts an application for CKD patients without diabetes.
October 8, 2026
Novartis wins FDA approval for Rhapsido in symptomatic dermographism, expanding its chronic hives opportunity as pipeline setbacks raise pressure for growth.
October 8, 2026
WHIPPANY, N.J., October 08, 2026--Bayer today announced a partnership with actress and menopause advocate Melissa Joan Hart to increase awareness about Lynkuet® (elinzanetant) 60mg capsules, Bayer’s F...
October 8, 2026
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco...
October 8, 2026
Ahead of the openings of Frieze London and Art Basel Paris, Artprice announces the publication of its 33rd annual Contemporary Art Market Report, examining a market undergoing profound change.
October 8, 2026
135-Page Report Tracks Bayer and Merck's ADEMPAS (Riociguat) as the Leading Therapy as Combination Regimens and Balloon Pulmonary Angioplasty Reshape CTEPH TreatmentDublin, Oct. 08, 2026 (GLOBE NEWSWI...
October 8, 2026
Investing.com - The U.S. Food and Drug Administration accepted Bayer’s supplemental New Drug Application for Kerendia (finerenone) to treat adults with chronic kidney disease without diabetes, the com...
October 8, 2026
Today, Schouw & Co. hosts a Capital Markets Day in Copenhagen, Denmark. The Capital Markets Day will focus, among other things, on the continued strength of the conglomerate model following the succes...
October 8, 2026